"10.1371_journal.pone.0041564","plos one","2012-07-24T00:00:00Z","Lili C Kudo; Nancy Vi; Zhongcai Ma; Tony Fields; Nuraly K Avliyakulov; Michael J Haykinson; Anatol Bragin; Stanislav L Karsten","NeuroInDx, Inc., Signal Hill, California, United States of America; Division of Neuroscience, Department of Neurology, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, California, United States of America; Department of Neurology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America","Conceived and designed the experiments: AB MJH LCK SLK. Performed the experiments: AB SLK NV ZM TF NKA LCK. Analyzed the data: AB SLK NV ZM TF NKA LCK. Contributed reagents/materials/analysis tools: SLK AB MJH LCK. Wrote the paper: SLK LCK.","The authors have read the journalâ€™s policy and have the following conflicts: AB, SLK and LCK are co-owners of NeuroInDx, Inc. NV is a former employee of NeuroInDx, Inc. CTAS is a product under development. SLK and AB are the inventors of the technology. U.S. patent for CTAS is currently pending. Consultations regarding CTAS design were received from engineering team of Omnica, Inc. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.","2012","07","Lili C Kudo","LCK",8,TRUE,4,7,7,2,TRUE,TRUE,FALSE,0,NA,FALSE
